A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
This study is currently recruiting participants.
Verified September 2011 by SBI Biotech Co., Ltd.
Sponsor:
SBI Biotech Co., Ltd.
Information provided by:
SBI Biotech Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01035216
First received: December 17, 2009
Last updated: September 26, 2011
Last verified: September 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2012 |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |